Rowasa and Doxycycline drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rowasa (mesalamine) and Doxycycline (doxycycline hyclate). Common drug interactions include depression among females and cardiac hypertrophy among males.
The phase IV clinical study analyzes what interactions people have when they take Rowasa and Doxycycline. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Rowasa?
Rowasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 943 Rowasa users. Check the latest studies of Rowasa.
What is Doxycycline?
Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 60,866 Doxycycline users. Check the latest studies of Doxycycline.
23 people who take Rowasa and Doxycycline together, and have interactions are studied.

What are the common drug interactions of Rowasa and Doxycycline, by gender? *:
female:
- Depression
- Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
- Inflammatory bowel disease
- Malignant melanoma (skin cancer rises from melancytes)
- Renal failure acute (rapid kidney dysfunction)
- Uveitis (inflammation of the uvea)
- Myalgia (muscle pain)
- Headache (pain in head)
- Muscular weakness (muscle weakness)
- Pain in extremity
male:
- Cardiac hypertrophy (thickening of the heart muscle)
- Chest pain
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Pericarditis (inflammation of the pericardium)
- Chronic kidney disease
- Dehydration (dryness resulting from the removal of water)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
What are the common drug interactions of Rowasa and Doxycycline, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Dehydration (dryness resulting from the removal of water)
10-19:
- Chest pain
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Diarrhoea haemorrhagic (bloody diarrhoea)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Insomnia (sleeplessness)
- Myocarditis (inflammation of heart muscle myocardium)
- Pericarditis (inflammation of the pericardium)
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Pyrexia (fever)
- Abdominal pain lower
20-29:
n/a
30-39:
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Depression
- Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
- Inflammatory bowel disease
- Malignant melanoma (skin cancer rises from melancytes)
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Renal failure acute (rapid kidney dysfunction)
- Uveitis (inflammation of the uvea)
- Myalgia (muscle pain)
- Headache (pain in head)
40-49:
- Vasculitis necrotising (inflammation and damage to blood vessels)
50-59:
- Blood creatinine increased
- Blood urea increased
- Inflammatory bowel disease
- Malignant melanoma (skin cancer rises from melancytes)
- Muscular weakness (muscle weakness)
- Myalgia (muscle pain)
- Pain in extremity
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Renal failure acute (rapid kidney dysfunction)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
60+:
n/a
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 21 people, 91.30%
- Upper Respiratory Tract Infection: 11 people, 47.83%
- Kidney Infection (Pyelonephritis): 11 people, 47.83%
- Depression: 11 people, 47.83%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 11 people, 47.83%
- Pharyngitis (inflammation of the pharynx, causing a sore throat): 5 people, 21.74%
- Menometrorrhagia (a condition in which prolonged or excessive uterine bleeding occurs irregularly and more frequently than normal): 4 people, 17.39%
- Hidradenitis (chronic disease of a type of sweat gland): 4 people, 17.39%
* Approximation only. Some reports may have incomplete information.
Do you take Rowasa and Doxycycline?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rowasa (943 reports)
- Doxycycline (60,866 reports)
Browse all drug interactions of Rowasa and Doxycycline:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rowasa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Doxycycline:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rowasa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Doxycycline and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on mesalamine and doxycycline hyclate (the active ingredients of Rowasa and Doxycycline, respectively), and Rowasa and Doxycycline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Propecia cause Agitation Aggravated? - a second ago
- Kidney Transplant and Arrhythmias - a second ago
- Could Cetirizine Hydrochloride cause Diarrhea? - a second ago
- Could Cetirizine Hydrochloride cause Stools - Watery? - 2 seconds ago
- Whipple'S Disease and Fever - 9 seconds ago
- Drug interactions of Fentanyl and Alendronate Sodium - 10 seconds ago
- Could Celebrex cause Fluid Retention? - 11 seconds ago
- Drug interactions of Creon and Lenalidomide - 14 seconds ago
- Acute Myeloid Leukaemia Aggravated and Diastolic Dysfunction - 20 seconds ago
- Drug interactions of Methocarbamol and Copaxone - 30 seconds ago